Posttherapy imaging of musculoskeletal neoplasms

Radiologic Clinics of North America

Volumn 49, Issue 6, 2011, Pages 1307-1323

  Garner, Hillary Warren ^a   Kransdorf, Mark J ^a   Peterson, Jeffrey J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Imaging; Musculoskeletal; Posttherapy; Sarcoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; LIMB SALVAGE; MUSCULOSKELETAL DISEASE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; OUTCOME ASSESSMENT; PLASTIC SURGERY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RECURRENT CANCER; REVIEW; SOFT TISSUE SARCOMA; SYSTEMIC THERAPY; TREATMENT RESPONSE; TUMOR VOLUME;

BONE NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 82455162821     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2011.07.011     Document Type: Review

References (62)

1. Coindre J.M., Terrier P., Bui N.B., et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996, 14(3):869-877.
2. Pisters P.W., Leung D.H., Woodruff J., et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996, 14(5):1679-1689.
3. Aljubran A.H., Griffin A., Pintilie M., et al. Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Ann Oncol 2009, 20(6):1136-1141.
4. Bacci G., Briccoli A., Longhi A., et al. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol 2005, 44(7):748-755.
5. Kempf-Bielack B., Bielack S.S., Jurgens H., et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 2005, 23(3):559-568.
6. Cormier J.N., Pollock R.E. Soft tissue sarcomas. CA Cancer J Clin 2004, 54(2):94-109.
7. Ferrari S., Briccoli A., Mercuri M., et al. Late relapse in osteosarcoma. J Pediatr Hematol Oncol 2006, 28(7):418-422.
8. Hauben E.I., Bielack S., Grimer R., et al. Clinico-histologic parameters of osteosarcoma patients with late relapse. Eur J Cancer 2006, 42(4):460-466.
9. Strauss S.J., McTiernan A., Whelan J.S. Late relapse of osteosarcoma: implications for follow-up and screening. Pediatr Blood Cancer 2004, 43(6):692-697.
10. Anract P., Coste J., Vastel L., et al. Rev Chir Orthop Reparatrice Appar Mot 2000, 86(3):278-288. [in French].
11. Biau D.J., Larousserie F., Thevenin F., et al. Results of 32 allograft-prosthesis composite reconstructions of the proximal femur. Clin Orthop Relat Res 2010, 468(3):834-845.
12. Farid Y., Lin P.P., Lewis V.O., et al. Endoprosthetic and allograft-prosthetic composite reconstruction of the proximal femur for bone neoplasms. Clin Orthop Relat Res 2006, 442:223-229.
13. Zehr R.J., Enneking W.F., Scarborough M.T. Allograft-prosthesis composite versus megaprosthesis in proximal femoral reconstruction. Clin Orthop Relat Res 1996, 322:207-223.
14. Garner H.W., Kransdorf M.J., Bancroft L.W., et al. Benign and malignant soft-tissue tumors: posttreatment MR imaging. Radiographics 2009, 29(1):119-134.
15. Hwang S., Lefkowitz R., Landa J., et al. Local changes in bone marrow at MRI after treatment of extremity soft tissue sarcoma. Skeletal Radiol 2009, 38(1):11-19.
16. Fox M.G., Bancroft L.W., Peterson J.J., et al. MRI appearance of myocutaneous flaps commonly used in orthopedic reconstructive surgery. AJR Am J Roentgenol 2006, 187(3):800-806.
17. Fitzgerald JJ, Roberts CC, Daffner RH, et al. Expert panel on musculoskeletal imaging. ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors. Reston (VA): American College of Radiology (ACR); 2011.
18. Patel S.R., Zagars G.K., Pisters P.W. The follow-up of adult soft-tissue sarcomas. Semin Oncol 2003, 30(3):413-416.
19. Eustace S., Goldberg R., Williamson D., et al. MR imaging of soft tissues adjacent to orthopaedic hardware: techniques to minimize susceptibility artefact. Clin Radiol 1997, 52(8):589-594.
20. Lee M.J., Kim S., Lee S.A., et al. Overcoming artifacts from metallic orthopedic implants at high-field-strength MR imaging and multi-detector CT. Radiographics 2007, 27(3):791-803.
21. Suh J.S., Jeong E.K., Shin K.H., et al. Minimizing artifacts caused by metallic implants at MR imaging: experimental and clinical studies. AJR Am J Roentgenol 1998, 171(5):1207-1213.
22. White L.M., Kim J.K., Mehta M., et al. Complications of total hip arthroplasty: MR imaging-initial experience. Radiology 2000, 215(1):254-262.
23. Chang S.D., Lee M.J., Munk P.L., et al. MRI of spinal hardware: comparison of conventional T1-weighted sequence with a new metal artifact reduction sequence. Skeletal Radiol 2001, 30(4):213-218.
24. Olsen R.V., Munk P.L., Lee M.J., et al. Metal artifact reduction sequence: early clinical applications. Radiographics 2000, 20(3):699-712.
25. Bamberg F., Dierks A., Nikolaou K., et al. Metal artifact reduction by dual energy computed tomography using monoenergetic extrapolation. Eur Radiol 2011.
26. Varma D.G., Jackson E.F., Pollock R.E., et al. Soft-tissue sarcoma of the extremities. MR appearance of post-treatment changes and local recurrences. Magn Reson Imaging Clin N Am 1995, 3(4):695-712.
27. Pezzi C.M., Pollock R.E., Evans H.L., et al. Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg 1990, 211(4):476-481.
28. Fuller B.G. The role of radiation therapy in the treatment of bone and soft-tissue sarcomas. Musculoskeletal cancer surgery. Treatment of sarcomas and allied diseases 2001, 85-133. Kluwer, Dordrecht. M. Malawer (Ed.).
29. Dunst J., Schuck A. Role of radiotherapy in Ewing tumors. Pediatr Blood Cancer 2004, 42(5):465-470.
30. Krasin M.J., Rodriguez-Galindo C., Billups C.A., et al. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 2004, 60(3):830-838.
31. Machak G.N., Tkachev S.I., Solovyev Y.N., et al. Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities. Mayo Clin Proc 2003, 78(2):147-155.
32. Khatri V.P., Goodnight J.E. Extremity soft tissue sarcoma: controversial management issues. Surg Oncol 2005, 14(1):1-9.
33. Blomlie V., Rofstad E.K., Skjonsberg A., et al. Female pelvic bone marrow: serial MR imaging before, during, and after radiation therapy. Radiology 1995, 194(2):537-543.
34. Stevens S.K., Moore S.G., Kaplan I.D. Early and late bone-marrow changes after irradiation: MR evaluation. AJR Am J Roentgenol 1990, 154(4):745-750.
35. Kauczor H.U., Dieti B., Brix G., et al. Fatty replacement of bone marrow after radiation therapy for Hodgkin disease: quantification with chemical shift imaging. J Magn Reson Imaging 1993, 3(4):575-580.
36. Mumber M.P., Greven K.M., Haygood T.M. Pelvic insufficiency fractures associated with radiation atrophy: clinical recognition and diagnostic evaluation. Skeletal Radiol 1997, 26(2):94-99.
37. Fu A.L., Greven K.M., Maruyama Y. Radiation osteitis and insufficiency fractures after pelvic irradiation for gynecologic malignancies. Am J Clin Oncol 1994, 17(3):248-254.
38. Weber M., Hasler P., Gerber H. Insufficiency fractures of the sacrum. Twenty cases and review of the literature. Spine (Phila Pa 1976) 1993, 18(16):2507-2512.
39. Richardson M.L., Zink-Brody G.C., Patten R.M., et al. MR characterization of post-irradiation soft tissue edema. Skeletal Radiol 1996, 25(6):537-543.
40. Biondetti P.R., Ehman R.L. Soft-tissue sarcomas: use of textural patterns in skeletal muscle as a diagnostic feature in postoperative MR imaging. Radiology 1992, 183(3):845-848.
41. Vanel D., Shapeero L.G., De Baere T., et al. MR imaging in the follow-up of malignant and aggressive soft-tissue tumors: results of 511 examinations. Radiology 1994, 190(1):263-268.
42. Moore L.F., Kransdorf M.J., Buskirk S.J., et al. Radiation-induced pseudotumor following therapy for soft tissue sarcoma. Skeletal Radiol 2009, 38(6):579-584.
43. Poon-Chue A., Menendez L., Gerstner M.M., et al. MRI evaluation of post-operative seromas in extremity soft tissue sarcomas. Skeletal Radiol 1999, 28(5):279-282.
44. Paz I.B., Wagman L.D., Terz J.J., et al. Extended indications for functional limb-sparing surgery in extremity sarcoma using complex reconstruction. Arch Surg 1992, 127(11):1278-1281.
45. Choi H., Varma D.G., Fornage B.D., et al. Soft-tissue sarcoma: MR imaging vs sonography for detection of local recurrence after surgery. AJR Am J Roentgenol 1991, 157(2):353-358.
46. Costelloe C.M., Kumar R., Yasko A.W., et al. Imaging characteristics of locally recurrent tumors of bone. AJR Am J Roentgenol 2007, 188(3):855-863.
47. Charest M., Hickeson M., Lisbona R., et al. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases. Eur J Nucl Med Mol Imaging 2009, 36(12):1944-1951.
48. el-Zeftawy H., Heiba S.I., Jana S., et al. Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma. Cancer Biother Radiopharm 2001, 16(1):37-46.
49. Peterson J.J. F-18 FDG-PET for detection of osseous metastatic disease and staging, restaging, and monitoring response to therapy of musculoskeletal tumors. Semin Musculoskelet Radiol 2007, 11(3):246-260.
50. Bastiaannet E., Groen H., Jager P.L., et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev 2004, 30(1):83-101.
51. Piperkova E., Mikhaeil M., Mousavi A., et al. Impact of PET and CT in PET/CT studies for staging and evaluating treatment response in bone and soft tissue sarcomas. Clin Nucl Med 2009, 34(3):146-150.
52. Benz M.R., Czernin J., Allen-Auerbach M.S., et al. FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clin Cancer Res 2009, 15(8):2856-2863.
53. Bredella M.A., Caputo G.R., Steinbach L.S. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas. AJR Am J Roentgenol 2002, 179(5):1145-1150.
54. Hawkins D.S., Rajendran J.G., Conrad E.U., et al. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-d-glucose positron emission tomography. Cancer 2002, 94(12):3277-3284.
55. Iagaru A., Masamed R., Chawla S.P., et al. F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas. Clin Nucl Med 2008, 33(1):8-13.
56. Heusner T., Golitz P., Hamami M., et al. " One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?. Eur J Radiol 2009.
57. McCarville M.B., Christie R., Daw N.C., et al. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol 2005, 184(4):1293-1304.
58. Peterson J.J., Kransdorf M.J., O'Connor M.I. Diagnosis of occult bone metastases: positron emission tomography. Clin Orthop Relat Res 2003, (415 Suppl):S120-S128.
59. Franzius C., Daldrup-Link H.E., Wagner-Bohn A., et al. FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Ann Oncol 2002, 13(1):157-160.
60. Klaeser B., Mueller M.D., Schmid R.A., et al. PET-CT-guided interventions in the management of FDG-positive lesions in patients suffering from solid malignancies: initial experiences. Eur Radiol 2009, 19(7):1780-1785.
61. O'Sullivan P.J., Rohren E.M., Madewell J.E. Positron emission tomography-CT imaging in guiding musculoskeletal biopsy. Radiol Clin North Am 2008, 46(3):475-486. v.
62. Bestic J.M., Peterson J.J., Bancroft L.W. Use of FDG PET in staging, restaging, and assessment of therapy response in Ewing sarcoma. Radiographics 2009, 29(5):1487-1500.